Back to Markets
TRTrevi Therapeutics Inc

Trevi Therapeutics Inc

TRVINASDAQ NMS - GLOBAL MARKET
Health CarePharmaceuticals

$14.14

-0.310000 (-2.15%)

As of 05/29/26 EDT · USD

Compare
Low: $5.38Current: $14.14High: $16.12

Key Statistics

Open

$14.32

Day High

$14.56

Day Low

$14.11

Prev. Close

$14.45

VolumeShares traded today.

950.93K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$2.01B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-43.72

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$16.12

52W LowLowest price over the past 52 weeks.

$5.38

50D MAAverage closing price over the last 50 trading days.

$13.52

200D MAAverage closing price over the last 200 trading days.

$11.35

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-0.1%

1M

+2.3%

6M

+24.5%

YTD

+18.9%

1Y

+117.2%

About

Nalbuphine, sold under the brand names Nubain among others, is an opioid analgesic which is used in the treatment of pain. It is given by injection into a vein, muscle, or fat.

www.trevitherapeutics.com/

Company Facts

SectorHealth Care
IndustryPharmaceuticals
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade TRVI

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.